esc eas guidelines for the management of dyslipidaemias -slideset
TRANSCRIPT
-
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
1/40
www.escardio.org
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
2/40
www.escardio.org
BACKGROUND
CLASSES OF RECOMMENDATIONS
LEVEL OF EVIDENCE
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
3/40
www.escardio.org
Classes of recommendations
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
4/40
www.escardio.org
Levels of evidence
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
5/40
www.escardio.org
THE APPROACH
GLOBAL RISK
LEVELS OF RISK GRADING
INTERVENTION LEVELS
TARGETS
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
6/40
-
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
7/40
www.escardio.org
SCORE chart: 10 year risk of fatal cardiovasculardisease (CVD) in populations at high CVD risk
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
8/40
www.escardio.org
Risk function without high-density lipoprotein-cholesterol (HDL-C)for men in populations at high cardiovascular disease risk
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
9/40
www.escardio.org
Relative risk chart
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
10/40
www.escardio.org
Risk will also be higher than indicated in the charts in:
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
11/40
www.escardio.org
THE APPROACH
GLOBAL RISK
LEVELS OF RISK GRADING
INTERVENTION LEVELS
TARGETS
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
12/40
www.escardio.org
Intervention strategies as a functionof total CV risk and LDL-C level
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
13/40
www.escardio.org
THE APPROACH
GLOBAL RISK
LEVELS OF RISK GRADING
INTERVENTION LEVELS
TARGETS
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
14/40
www.escardio.org
Recommendations for treatment targets for LDL-C
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
15/40
www.escardio.org
THE APPROACH
LIPID ANALYSES
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
16/40
www.escardio.org
Recommendations for lipid analyses astreatment target in the prevention of CVD
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
17/40
www.escardio.org
THE APPROACH
LIFESTYLE CHANGES
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
18/40
www.escardio.org
Definition of central obesity
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
19/40
www.escardio.org
Dietary recommendations to lower TC and LDL-C
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
20/40
www.escardio.org
Summary of lifestyle measures and healthy foodchoices for managing total cardiovascular risk
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
21/40
www.escardio.org
THE APPROACH
DRUG THERAPY
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
22/40
www.escardio.org
Recommendations for the pharmacologicaltreatment of hypercholesterolaemia
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
23/40
-
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
24/40
www.escardio.org
Recommendations if drug treatmentof low HDL-C is considered
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
25/40
www.escardio.org
THE APPROACH
GENETIC DYSLIPIDAEMIAS
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
26/40
www.escardio.org
Genetic disorders of lipoprotein metabolism
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
27/40
-
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
28/40
www.escardio.org
THE APPROACH
SPECIFIC POPULATIONS
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
29/40
www.escardio.org
Management of dyslipidaemia in women
R d ti f t t t f
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
30/40
www.escardio.org
Recommendations for treatment ofdyslipidaemia in the elderly
R d ti f t t t f
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
31/40
www.escardio.org
Recommendations for treatment ofdyslipidaemia in diabetes
Recommendations for lipid lowering drugs
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
32/40
www.escardio.org
Recommendations for lipid lowering drugsin patients with moderate to severe CKD
(stages 24, GFR 1589 mL/min/1.73 m2)
R d ti f li id l i
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
33/40
www.escardio.org
Recommendations for lipid-loweringdrugs in patients with PAD
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
34/40
THE APPROACH
-
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
35/40
www.escardio.org
THE APPROACH
ADHERENCE AND COMPLIANCE
Hints to help adherence to lifestyle changes
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
36/40
www.escardio.org
Hints to help adherence to lifestyle changes
Tips to help compliance with multiple drug therapies
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
37/40
www.escardio.org
Tips to help compliance with multiple drug therapies
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
38/40
A t ti i d t l i
-
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
39/40
www.escardio.org
A systematic review and meta-analysison the therapeutic equivalence of statins
THE PUBLICATION
http://www.escardio.org/http://www.escardio.org/ -
8/3/2019 ESC EAS Guidelines for the Management of Dyslipidaemias -Slideset
40/40
di
THE PUBLICATION
doi:10.1016/j.atherosclerosis.2011.06.028
http://www.escardio.org/http://www.escardio.org/